Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal Transplantation-Reference-Cited by-同舟云学术

Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal Transplantation

Published:2010-12-27 Issue:12 Volume:90 Page:1536-1541
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Raggi Matthias C.,Siebert Stephanie B.,Steimer Werner,Schuster Tibor,Stangl Manfred J.,Abendroth Dietmar K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference30 articles.

1. Immunosuppressive drugs for kidney transplantation.;Halloran;N Engl J Med,2004

2. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection.;Halloran;Transplantation,1997

3. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.;Shaw;Am J Transplant,2003

4. An inosine 5′-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.;Winnicki;Pharmacogenomics J,2010

5. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.;Meier-Kriesche;Transplantation,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review;Bioanalysis;2022-11

2. The combination of exposure to Tacrolimus, mycophenolic acid, Inosine 5′‐Monophosphate Dehydrogenase activity and inhibition in the first week define early histological outcomes in renal transplant recipients;Clinical Transplantation;2022-10-26

3. Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation;Expert Review of Clinical Pharmacology;2021-10-07

4. ZASTOSOWANIE METOD ANALITYCZNYCH W OZNACZANIU AKTYWNOŚCI DEHYDROGENAZY INOZYNOMONOFOSFORANOWEJ (IMPDH) PODCZAS TERAPII IMMUNOSUPRESYJNEJ;Prospects in Pharmaceutical Sciences;2020-08-07

5. Inosine 5′-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients;Transplantation;2020-06-01